SmartTRAK is excited to be attending the #AVA Association for Vascular Access 2019 Annual Scientific Meeting taking place October 4-7, 2019 at Caesars Palace in Las Vegas, NV.

Susan Paquette, Vice President and General Manager, Wound, will be representing SmartTRAK at AVA.

Susan has been with SmartTRAK since 2011, leading the Wound efforts. Prior to SmartTRAK, Susan was with 3M for 20+ years' holding leadership positions in new business development, R&D, international and marketing. 

If you would like to meet with Susan for SmartTRAK's insights into the Vascular Access market at #AVA2019, please click to schedule a meeting. To read a SmartTRAK Market Outlook article Susan wrote "Preventing Peripheral IV Failure: The Next Big Thing in Vascular Access" following AVA 2018, click below...

An impressive quarter of growth, driven by CTPs in the US, single-use NPWT globally and a solid performance for Advanced Dressings.

For Q219, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +6.2% YoY. Acelity remained the AWC market leader, while Advanced Dressings saw strong growth from Mölnlycke and Coloplast, offset by weak performance from Smith & Nephew and ConvaTec. The total market reached...

Among the many topics covered in theQ219 Advanced Wound Care Market Recap* are:

The US market for Hemostats and Sealants grew +6.4% YoY in Q219, a slightly lower growth rate vs Q119, with biologic sealants and thrombin hemostats driving the increase.

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the US Hemostats and Sealants market, except Ethicon, experienced revenue growth in Q219. Leading the way was Baxter, as it capitalized on Ethicon’s supply problems with Surgiflo. Cryolife and Becton Dickinson (BD) both posted strong gains. Ethicon still continued to dominate the overall US Hemostat and Sealants market, with a 40.7% share, down from 48.6% share in Q119. Most of this share shifted to Baxter as the Company continues to chip away at...

Among the many topics covered in the Q219 US Hemostats and Sealants Market Recap* are:

Terry Hayslett is SmartTRAK's Senior Analyst, Advanced Wound Care. Terry has 20+ years of diverse healthcare experience, including provider reimbursement, corporate compliance, business development, strategic planning, financial analysis and health economics. Before joining SmartTRAK, Terry was  responsible for the global funding and reimbursement function at Mölnlycke Health Care. 

As a Senior Analyst for Wound Care, Terry will manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules and provide reimbursement and regulatory support across all AWC modules.

Meet Terry Hayslett:

1. What is your role with SmartTRAK? As a Senior Analyst for Wound Care, my role is to manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules. I also provide reimbursement and regulatory support across all AWC modules.

SmartTRAK analysts Susan Paquette and Lennart Stadler on European market trends and emerging products and technologies showcased at EWMA 2019.

In many ways, the European Wound Management Association (EWMA) annual meeting is a microcosm of the latest wound care trends in Europe and provides a glimpse of what’s on the horizon in the worldwide (WW) market for Advanced Wound Care (AWC).

SmartTRAK hosted a tour, dinner reception and briefing at Gothenburg's Universeum before EWMA 2019. Attendees were treated to a private tour of the Universeum and the Ocean Zone prior to dinner and the briefing, entitled Trends, Opportunities and Innovations in Advanced Wound Care, with a special focus on the European market.

SmartTRAK examines what the combined company will look like in terms of revenue, product portfolios, financial performance and more.

In its biggest deal to date, 3M recently announced the acquisition of wound care giant Acelity and its KCI subsidiaries for $6.7B, a move that propels 3M to the top of the Advanced Wound Care (AWC) market when the deal closes in H219.

Dr. Ronald Baxter of Baylor University and Spectral MD, discusses the Spectral MD DeepView Wound Imaging System in predicting DFU wound healing utilizing artificial intelligence in an interview with SmartTRAK.

Spectral MD has developed the DeepView Wound Imaging System to utilize real-time data and artificial intelligence to predict wound healing. The Company has seen initial success in burn treatment and is now moving into validation of their system for diabetic foot ulcers (DFUs) with the goal to predict a wound’s healing potential at the initial clinical visit.

To learn more about Spectral MD’s multi-spectral imaging system, DeepView; the pilot DFU study to analyze the predictive qualities of its artificial intelligence deep learning program, and the company’s plans moving forward; SmartTRAK interviewed Dr. Ronald Baxter, of Baylor University and Spectral MD.

A transcript of SmartTRAK’s interview with Dr. Baxter is below. To view the interview recorded live at SAWC Spring 2019, click on the following video.

The SmartTRAK analyst team is expanding and we are looking for an experienced and motivated individual who would like to manage one or more of our Advanced Wound Care modules, with a focus on the European markets. As you know, all of our SmartTRAK analysts are former marketing, business development or competitive intelligence professionals with one of the major medical device manufacturers and, in fact, most have come to us via recommendations from our subscribers. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add to the SmartTRAK platform.